Our firm is investigating J. Alden Associates, Inc. broker and Alden Investment Group investment adviser representative Nathan Daniel Goad (CRD# 5421740), based in Wayne, Pennsylvania and Largo, Florida, for potential private placement–related misconduct.
Financial Advisor’s Career History
According to FINRA BrokerCheck, Nathan Daniel Goad entered the securities industry in 2007 and is currently dually registered with both a broker-dealer and an investment advisory firm.
Mr. Goad is presently:
- A General Securities Representative with J. Alden Associates, Inc. (CRD# 40002) in Wayne, Pennsylvania, registered since January 7, 2022.
- An Investment Adviser Representative with Alden Investment Group (CRD# 317077), with branch locations in Wayne, Pennsylvania and Largo, Florida, registered since July 28, 2022.
His prior registration history includes:
- Total Solutions Enterprise (Investment Adviser), Bellaire Bluffs, FL – 03/2022 to 12/2022
- Alden Capital (Investment Adviser), Belleair Bluffs, FL – 05/2021 to 11/2022
- Cetera Investment Advisers LLC (Investment Adviser), Clearwater, FL – 08/2020 to 05/2021
- Cetera Investment Services LLC (Broker), Clearwater, FL – 05/2015 to 05/2021
- ARS Wealth Advisors (Investment Adviser), St. Petersburg, FL – 07/2011 to 11/2014
- Transamerica Financial Advisors, Inc. (Broker), St. Petersburg, FL – 01/2008 to 04/2011
- Intersecurities, Inc. (Broker), Tampa, FL – 09/2007 to 11/2007
BrokerCheck also reflects that Mr. Goad has passed the SIE, Series 6, Series 7, Series 63, and Series 65 exams and has reported the Certified Financial Planner™ professional designation.
Nathan Goad Fraud Allegations and Investor Complaints Explained
FINRA’s BrokerCheck report for Nathan Daniel Goad discloses three pending customer disputes, each alleging that he recommended unsuitable private placement and other direct investment offerings and committed breach of fiduciary duty, negligence, and misrepresentation in connection with those sales. All three matters are pending in FINRA arbitration and no findings have yet been made.
Collectively, the customers are seeking more than $6.5 million in alleged damages tied to direct investments and DPP/LP interests.
Below is a summary of the reported disputes:
- Disclosure 1 – FINRA Arbitration 25-01635 (Filed August 8, 2025; Complaint Received September 15, 2025)
- Firm involved: J. Alden Associates, Inc.
- Product type: Direct Investment – DPP & LP Interests (including private placements).
- Allegations: Breach of fiduciary duty, negligence, and misrepresentation based on recommendations of private placements between March 2022 and June 2025.
- Claimed damages: $3,808,192.49.
- Status: Customer dispute pending in FINRA arbitration.
- Disclosure 2 – FINRA Arbitration #25-00701 (Filed March 26, 2025; Complaint Received April 14, 2025)
- Firm involved: J. Alden Associates, Inc.
- Product type: Direct Investment – DPP & LP Interests.
- Allegations: Breach of fiduciary duty, negligence, and misrepresentation arising from private placement recommendations between October 2022 and January 2023.
- Claimed damages: $500,000.00.
- Status: Customer dispute pending in FINRA arbitration.
- Disclosure 3 – FINRA Arbitration 25-00678 (Filed April 1, 2025; Complaint Received April 25, 2025)
- Firm involved: J. Alden Associates, Inc.
- Product type: Direct Investment – DPP & LP Interests (including private placements).
- Allegations: Breach of fiduciary duty, negligence, and misrepresentation tied to private placements recommended between July 2021 and January 2023, plus an additional placement in September 2024 after the customer left Mr. Goad and J. Alden.
- Claimed damages: $2,200,000.00.
- Status: Customer dispute pending in FINRA arbitration.
Key themes across the pending disputes
- Concentrated use of complex direct investments and private placement offerings, including DPP and LP interests.
- Allegations that Mr. Goad failed to act in the customers’ best interests, constituting breach of fiduciary duty, negligence, and misrepresentation.
- Claims that the recommendations were unsuitable and inconsistent with the investors’ risk tolerance and objectives.
- Significant claimed losses exceeding $6.5 million in the aggregate.
Investors who were sold similar private placement or DPP/LP products may have potential claims for private placement fraud or other forms of stockbroker misconduct, even if they are not parties to the pending arbitration cases.
To obtain a copy of Nathan Daniel Goad’s FINRA BrokerCheck report, visit this link.
Robert Wayne Pearce Is Committed to Recovering Your Investment Losses
(FINRA Rule 2111 — Suitability).
FINRA Rule 2111 requires brokers to have a reasonable basis to believe that any recommended transaction or investment strategy is suitable for the customer based on that customer’s investment profile, including factors like age, financial situation, risk tolerance, objectives, time horizon, and liquidity needs. In the pending allegations against Nathan Daniel Goad, customers claim that he recommended large allocations to illiquid private placements and DPP/LP interests between 2021 and 2025, resulting in multi-million-dollar losses. If the evidence shows that these high-risk products were inconsistent with the customers’ stated objectives or risk tolerance, or that he failed to fully explain the risks, arbitrators could find violations of the customer-specific suitability and reasonable-basis suitability components of Rule 2111.
(FINRA Rule 2010 — Standards of Commercial Honor).
FINRA Rule 2010 is a broad ethical rule requiring member firms and their associated persons to “observe high standards of commercial honor and just and equitable principles of trade” in the conduct of their business. Even where specific product or suitability rules are not technically violated, patterns of misleading sales pitches, failure to disclose material risks, or recommendations that place a broker’s interests ahead of the client’s can be charged as violations of Rule 2010. In cases like those pending against Mr. Goad—where customers allege breach of fiduciary duty, negligence, and misrepresentation in connection with complex private placements—FINRA or arbitrators may analyze whether his conduct fell below the ethical standards required by Rule 2010, particularly if the investors were encouraged to concentrate their portfolios in illiquid, high-commission offerings.
(FINRA Rule 3110 — Supervision).
Although the BrokerCheck disclosures focus on customer disputes naming Nathan Daniel Goad, claims of this type often raise issues under FINRA Rule 3110, which requires brokerage firms to establish, maintain, and enforce a supervisory system reasonably designed to achieve compliance with securities laws and FINRA rules. If multiple customers at J. Alden Associates or affiliated entities were concentrated in the same or similar private placement products, investors may argue that the firm failed to supervise Mr. Goad’s recommendations, failed to review the suitability of these offerings for each client, or failed to respond appropriately to red flags such as repeated complaints or large concentrations in risky DPP/LP interests. In arbitration, this supervision theory can be used to hold the firm liable—even if the broker alone made the specific recommendations at issue.
For over 45 years, Robert Wayne Pearce has helped investors recover losses caused by broker fraud, negligence, and unsuitable recommendations. His firm, The Law Offices of Robert Wayne Pearce, P.A., represents clients nationwide on a no-recovery, no-fee basis. Call (800) 732-2889 or email pearce@rwpearce.com for a free case review with an experienced securities attorney.
